Home » Topics » BioWorld Science

BioWorld Science
RSS

Novel target identified for long QT

Feb. 23, 2022

Sorrento's STI-9167 shows neutralizing activity against SARS-CoV-2 Omicron variants

Feb. 23, 2022

Cantargia reports non-GLP toxicology and pharmacokinetic data on CAN-10

Feb. 23, 2022

JBC-1847 proven effective against Staphylococcus aureus infection

Feb. 23, 2022

ALPHA-1062 shown to be neuroprotective in rodent model of traumatic brain injury

Feb. 23, 2022

Actinium and AVEO collaborate to develop novel Ac-225 ErbB3-targeted radiotherapy

Feb. 23, 2022

Phio's INTASYL-based antiviral compounds against SARS-CoV-2 enter in vivo testing

Feb. 23, 2022

Sema4 and BioSymetrics partner on drug discovery in cardiovascular, rare and neurological diseases

Feb. 23, 2022

Code Bio and Takeda collaborate on gene therapies for rare diseases

Feb. 23, 2022

Microlyse targets VWF and clears microvascular thrombosis

Feb. 23, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...